Applied Therapeutics, Inc. Retained Earnings
Applied Therapeutics, Inc. had Retained Earnings of -$636.36 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-13
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$636.36M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$617.37M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$596.03M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$574.21M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$636.36M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$617.37M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$596.03M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$574.21M 10-Q · filed 2025-11-13 |
| 2024-09-30 | -$618.22M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$549.63M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$552.52M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$468.59M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$430.91M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$388.54M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$358.96M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$348.82M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$334.39M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$315.29M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$289.44M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$266.31M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$239.16M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$210.74M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$184.91M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$160.73M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$137.04M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$107.20M 10-Q · filed 2020-08-11 |
| 2020-03-31 | -$79.14M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$66.77M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$49.14M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$38.42M 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$29.99M 10-Q · filed 2019-06-21 |
| 2018-12-31 | -$21.26M 10-K · filed 2020-03-13 |